Back
Amicus Therapeutics Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Sell
34
FOLD
Amicus Therapeutics
Last Price:
9.87
Seasonality Move:
7.75%
Sell
30
ALNY
Alnylam Pharmaceuticals
Last Price:
253.02
Seasonality Move:
7.55%
Sell
34
Amicus Therapeutics (FOLD)
is a Sell
Is Amicus Therapeutics a Buy, Sell or Hold?
- The current Amicus Therapeutics [FOLD] share price is $9.87. The Score for FOLD is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
- FOLD is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
- The current Alnylam Pharmaceuticals [ALNY] share price is $253.35. The Score for ALNY is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- ALNY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
FOLD Stock Price Chart
What is Amicus Therapeutics's stock price today?
-
The Amicus Therapeutics share price today is $9.87
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FOLD is experiencing buying pressure, which is a positive indicator for future bullish movement.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $253.35
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing buying pressure, which is a positive indicator for future bullish movement.
FOLD Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.4 | Sell |
Relative Strength Index (14 RSI): | 38.25 | Sell |
Chaikin Money Flow: | 826536 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (9.87 - 11.53) | Sell |
Bollinger Bands (100): | (10.16 - 11.54) | Sell |
ALNY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -8.33 | Sell |
Relative Strength Index (14 RSI): | 44.29 | Sell |
Chaikin Money Flow: | 851531 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (247.71 - 283.73) | Sell |
Bollinger Bands (100): | (248.8 - 281.72) | Sell |
FOLD Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 9.65 | Buy |
20-day SMA: | 10.48 | Sell |
50-day SMA: | 10.75 | Sell |
200-day SMA: | 10.94 | Sell |
8-day EMA: | 9.82 | Buy |
20-day EMA: | 10.25 | Sell |
50-day EMA: | 10.64 | Sell |
200-day EMA: | 10.98 | Sell |
ALNY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 243.36 | Buy |
20-day SMA: | 259.9 | Sell |
50-day SMA: | 271.86 | Sell |
200-day SMA: | 212.45 | Buy |
8-day EMA: | 249.92 | Buy |
20-day EMA: | 258.06 | Sell |
50-day EMA: | 264.29 | Sell |
200-day EMA: | 231.45 | Buy |
Amicus Therapeutics Earnings Growth & FOLD Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.57 per share, and an increase next year of $0.21 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.86 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.46 per share, and an increase next year of $0.61 per share.
Amicus Therapeutics Technical Analysis
Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Alnylam Pharmaceuticals Technical Analysis
Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |